U.S. investment for emerging therapeutic companies 2011-2022
Over the period 2013-2022, U.S. venture funding of emerging therapeutic companies totaled some 122 billion U.S. dollars. This graph depicts U.S. investment for emerging therapeutic companies in the periods of 2011-2020, 2012-2021, and 2013-2022, in billion U.S. dollars.